BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20216154)

  • 21. Treatment of pulmonary arterial hypertension.
    Ricachinevsky CP; Amantéa SL
    J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S153-65. PubMed ID: 17136291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An evidence-based approach to the management of pulmonary arterial hypertension.
    Coyne TC
    Curr Opin Cardiol; 2006 Sep; 21(5):526; author reply 526-7. PubMed ID: 16900019
    [No Abstract]   [Full Text] [Related]  

  • 23. [Selective vasodilation in the lung. Sildenafil improves physical capacity and prognosis].
    MMW Fortschr Med; 2007 May; 149(22):45. PubMed ID: 18069228
    [No Abstract]   [Full Text] [Related]  

  • 24. Citrulline, Viagra and BiDil--bad medicine.
    Czp A
    Altern Med Rev; 2005 Dec; 10(4):265-7. PubMed ID: 16400750
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral sildenafil reduces pulmonary hypertension after cardiac surgery.
    Trachte AL; Lobato EB; Urdaneta F; Hess PJ; Klodell CT; Martin TD; Staples ED; Beaver TM
    Ann Thorac Surg; 2005 Jan; 79(1):194-7; discussion 194-7. PubMed ID: 15620942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence.
    Raja SG; Danton MD; MacArthur KJ; Pollock JC
    J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):722-35. PubMed ID: 17023298
    [No Abstract]   [Full Text] [Related]  

  • 27. Revatio (sildenafil citrate) for the treatment of pulmonary arterial hypertension.
    Sahni J
    Conn Med; 2006; 70(6):381-3. PubMed ID: 16869470
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viagra and health: beyond ED.
    Harv Mens Health Watch; 2007 Aug; 12(1):1-4. PubMed ID: 18018319
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hypoxic pulmonary hypertension: modern views on pathogenesis and options for rational pharmacological correction].
    Strielkov IeV; Frantsuzova SB; Khromov OS
    Fiziol Zh (1994); 2012; 58(2):89-100. PubMed ID: 22873057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful maternal-foetal outcome using nitric oxide and sildenafil in pulmonary hypertension with atrial septal defect and HIV infection.
    Ng WP; Yip WL
    Singapore Med J; 2012 Jan; 53(1):e3-5. PubMed ID: 22252195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase type 5 inhibitors in pulmonary hypertension: a Hobson's choice for Indian patients.
    Saxena A
    Indian Heart J; 2007; 59(4):299-301. PubMed ID: 19126933
    [No Abstract]   [Full Text] [Related]  

  • 33. Viagra eases symptoms of pulmonary arterial hypertension in children.
    Senior K
    Drug Discov Today; 2005 Oct; 10(20):1337. PubMed ID: 16253866
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravenous prostacyclin in the treatment of persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide.
    Golzand E; Bar-Oz B; Arad I
    Isr Med Assoc J; 2005 Jun; 7(6):408-9. PubMed ID: 15984391
    [No Abstract]   [Full Text] [Related]  

  • 35. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
    Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
    Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary hypertension in children: a historical overview.
    Abman SH
    Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S4-9. PubMed ID: 20216162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination pharmacotherapy for severe neonatal pulmonary hypertension.
    Filan PM; McDougall PN; Shekerdemian LS
    J Paediatr Child Health; 2006 Apr; 42(4):219-20. PubMed ID: 16630327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary hypertension in patients with hemoglobinopathies: could a mechanism for dysfunction provide an avenue for novel therapeutics?
    Lin EE; Gladwin MT; Machado RF
    Haematologica; 2005 Apr; 90(4):441-4. PubMed ID: 15820937
    [No Abstract]   [Full Text] [Related]  

  • 39. Phosphodiesterase inhibitors for pulmonary hypertension.
    Galiè N; Rubin LJ; Simonneau G
    N Engl J Med; 2010 Feb; 362(6):559-60; author reply 560. PubMed ID: 20175298
    [No Abstract]   [Full Text] [Related]  

  • 40. [Primary arterial pulmonary hypertension and sildenafil: a case report from Dakar].
    Bouldouyre M; Dia D; Ba FK; Diop IB; Debonne JM
    Dakar Med; 2006; 51(2):78-80. PubMed ID: 17632981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.